Form 4 for FATE FATE THERAPEUTICS INC
Accepted 2022-04-04 00:00:00 ET · period of report 2021-04-01 · accession 0001209191-22-022495 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-04-04 | 2022-04-01 | FATE | TAHL CINDY | GC, Sec | M - OptEx | $5.22 | +25.0K | 214.2K | +13% | +$130.5K |
| D | 2022-04-04 | 2022-04-01 | FATE | TAHL CINDY | GC, Sec | S - Sale+OE | $38.85 | -25.0K | 189.2K | -12% | -$971.2K |
| DM | 2022-04-04 | 2022-04-01 | FATE | TAHL CINDY | GC, Sec | M - OptEx | $0.00 | -25.0K | 8,195 | -75% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-01 | M | A | 19,433 | $4.84 | 208,584 | D | — | — | |
| 2 | Common | Common Stock | 2022-04-01 | M | A | 5,567 | $6.55 | 214,151 | D | — | — | |
| 3 | Common | Common Stock | 2022-04-01 | S | D | 25,000 | $38.85 | 189,151 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-04-01 | M | D | 5,567 | $0.00 | 79,210 | D | $6.55 · — to 2028-01-16 | 5,567 Common Stock | (F2) This option is fully vested. |
| 5 | Derivative | Stock Option (Right to Buy) | 2022-04-01 | M | D | 19,433 | $0.00 | 8,195 | D | $4.84 · — to 2025-01-05 | 19,433 Common Stock | (F2) This option is fully vested. |